The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Wall street gave up early gains as investors continued to bathe in political uncertainty and then digested key earnings reports.

Alphabet’s earnings per share were four cents higher than tipped thanks to Cloud revenue and advertising on Google; GE Aerospace gained 7% on its earnings; but, Tesla’s earnings came in after the markets closed – and fell short of expectations. Tesla lost a big chunk of gains made the previous trading session.

All three key markets slid just a little – the Nasdaq dropped the most, losing 0.3%.

As a result the ASX200 is expected to shed just over 0.1%.

Back home, and a stock to watch today will be US-based bauxite and aluminium refiner Alcoa Corporation (ASX:AA1), as it debuts on the ASX after acquiring all of the shares in Alumina Ltd (ASX:AWC).

Also Pilbara Minerals (ASX:PLS) has revealed its June quarter earnings, reporting a 58% increase in revenue on higher spodumene sales and prices.

And, Arcadia Minerals (ASX:AM7) has vowed to have samples re-analysed and to review methodology, declaring it has ‘no confidence’ in the lithium brine results provided for assays from its Bitterwasser Project in Namibia. Results from two laboratories’ results were wildly different.

One Aussie dollar is buying US66.1 cents, gold has continued to rally, gaining half a per cent overnight to $2408.19; iron ore has been holding just above US$108 a tonne; oil has dropped 1.3% to around $77.40 a barrel; and, natural gas has dropped nearly 4% to $2.16.

More From The Market Online
Organised crime concept

Panic, paranoia, and gangland politics: HotCopper users react to Dubber’s missing $26M

HotCopper users have reacted to overnight reports Dubber has seen $26M disappear from its coffers due…
The Market Online Video

ASX Market Update: Bourse nears record approaching week’s end | November 22, 2024

The bourse is near record territory to close out the week on the back of a…
Image of four gold necklaces

Sales growth pushes Lovisa’s fortunes (and shares) upwards

Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and…
Image of eyes in closeup

Scientific conference spotlights PYC’s work on blindness disease treatment

PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat…